Andrew Cheng, MD, PhD Joins Akero Therapeutics as President and Chief Executive Officer

Akero's lead program AKR-001 to advance into Phase 2 clinical studies in 2019 Jonathan Young to serve as Executive Vice President and Chief Operating Officer CAMBRIDGE, Mass., Sept. 11, 2018 -- (Healthcare Sales & Marketing Network) -- Akero Therape... Biopharmaceuticals, Personnel Akero Therapeutics, non-alcoholic steatohepatitis
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news